A rare case of MGRS with immunotactoid glomerulopathy responding to bortezomib, dexamethasone, and rituximab

Abstract Patients with monoclonal gammopathy of renal significance should be treated with clone‐directed therapy against sources of monoclonal proteins in order to prevent progression to more advanced monoclonal gammopathies and renal failure.

Bibliographic Details
Main Authors: Chaoyuan Kuang, Kevin Quann, Agnes K. Liman, Roy Frye, Nawras Alshoubaki, Mohan Ramkumar, Andrew D. Liman
Format: Article
Published: Wiley 2020-10-01
Series:Clinical Case Reports
Online Access:https://doi.org/10.1002/ccr3.3044